CDC Panel Recommends Against Using CSL Biotherapies Flu Vaccine in Children Under 9

The Advisory Committee on Immunization Practices voted on Aug. 5 to withdraw a seasonal influenza vaccine manufactured by CSL Biotherapies from the U.S. market for children between the ages of 6 months and 8 years.